A revenue-generating, small-cap Canadian pharmaceutical company

Revenue Projected at $150,000,000 by 2025

Free
Message: AGORACOM Small Cap 60: Main Ingredient of Valeo Pharma’s Immune Booster Has Been Well Documented In Numerous Scientific Publications
Reply New Message
Prev Message Back To Forum Threaded View Next Message

AGORACOM Small Cap 60: Main Ingredient of Valeo Pharma’s Immune Booster Has Been Well Documented In Numerous Scientific Publications

posted on Jan 20, 2022 02:14PM
Log in to use the IP Check tool [?]

Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply